Nufarm share price: what to expect from full-year results
With the company recently revising its full-year earnings (EBITDA), below we take a look at some of the key things investors should be aware of before Nufarm reports its FY19 results.
When will Nufarm release its FY19 results?
Nufarm (ASX: NUF) is set to release its 2019 full-year results to the market on Monday, September 30 – before the market opens.
What is the company’s full-year guidance?
The company faced a challenging first-half in FY19, reporting profits (NPAT) that came in significantly lower than the prior corresponding period. The company also suspended its first-half dividend.
Amongst all this, there remains glimpses of growth, with Nufarm seeing good outcomes across its North America and Latin America business segments, as well as its seed technologies.
Primarily, while the company initially guided full-year 2019 earnings (EBITDA) in the range of A$440m to A$470m, Nufarm has since revised this figure downwards to around A$420m.
On this revised figure, CEO and Managing Director Greg Hunt said:
‘It's been a difficult year, with external headwinds impacting performance in three of our four major markets.’
Mr Hunt added that:
‘We are disappointed the work we have done to mitigate the external challenges has not been enough to achieve the targets we set for the financial year.’
Though the downgrade may be a disappointing development for investors, Nufarm (ASX: NUF) has taken proactive steps to sure up its balance sheet in the meantime.
For example, in August, the company raised A$97.5m through the placement of preference securities to current shareholders and the Sumitomo Chemical Company.
Nufarm share price: the analyst take
Though the Nufarm (ASX: NUF) share price has fallen approximately 22% since January, analysts continue to view the stock optimistically.
According to the Wall Street Journal, of the analysts covering the stock: five rate it a buy, while two rate it overweight. Only four analysts rate it a hold.
Overall, the average analyst consensus on Nufarm is overweight.
Morgan Stanley in particular seems positive on Nufarm's prospects, with the investment bank hitting the company with an overweight rating and a price target of A$7.10 per share.
On today’s share price of A$4.50, such a price target would imply potential upside of around 57%.
Ultimately, Morgan Stanley believes that Nufarm's latest share placement ranks as a key positive. However, the bank looks to be closely watching if Nufarm can effectively execute on its European acquisition agenda, citing poor performance on this front as a key risk.
As always, unfavourable weather conditions also pose a risk to the company's prospects, says Morgan Stanley.
This information has been prepared by IG, a trading name of IG Markets Limited. In addition to the disclaimer below, the material on this page does not contain a record of our trading prices, or an offer of, or solicitation for, a transaction in any financial instrument. IG accepts no responsibility for any use that may be made of these comments and for any consequences that result. No representation or warranty is given as to the accuracy or completeness of this information. Consequently any person acting on it does so entirely at their own risk. Any research provided does not have regard to the specific investment objectives, financial situation and needs of any specific person who may receive it. It has not been prepared in accordance with legal requirements designed to promote the independence of investment research and as such is considered to be a marketing communication. Although we are not specifically constrained from dealing ahead of our recommendations we do not seek to take advantage of them before they are provided to our clients.
Seize a share opportunity today
Go long or short on thousands of international stocks.
- Increase your market exposure with leverage
- Get commission from just 0.08% on major global shares
- Trade CFDs straight into order books with direct market access
Live prices on most popular markets